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Introduction
The bacterial species comprising the largest numbers of
human indigenous bacterial ﬂora are obligate anaerobes
(hereinafter referred to as anaerobic bacteria). On the other
hand, bacteria which are the focus of preventing postoper-
ative infections are those with high virulence, the numbers of
which are large, among bacteria comprising the indigenous
bacterial ﬂora at operative sites. Among the bacteria which
comprise indigenous bacterial ﬂora even after postoperative
infections, those resistant to prophylactic antibacterial
agents or the resistant bacteria encountered in hospitals
frequently become causes of cross infection. As a matter of
course, anaerobic bacteria are included among the former
bacteria. Therefore, measures to counter postoperative
infections, which must always take into consideration
anaerobic bacteria, are needed for prevention and treatment
of postoperative infections.
Anaerobic bacteria in prevention of postoperative
infections
There are two types of postoperative infection occurrence
patterns, surgical site infection (SSI) (infection of the site
directly inﬂuenced by operative procedures) and remote
infection (infection of a site not inﬂuenced by operative
procedures). The indications for prophylactic antibacterial
agents include SSI; since there is no convincing evidence for
suppression of the occurrence of remote infection with
prophylactic antibacterial agents, remote infection is
excluded from the indications for prophylactic use of anti-
bacterial agents [1]. Some SSI cases, in which the operative
ﬁeld is contaminated with a large amount of bacteria or
bacterial infection is present even before the operation, are
not included in the indications for prophylactic antibacterial
agents, because they should be treated, not be prevented.
Based on this concept, the indications for the prophylactic
use of antibacterial agents include operative wounds, which
are considered to be hygienic and semi-hygienic from the
viewpoint of the degree of contamination [2]. The risk of the
occurrence of infections of such wounds is expressed as:
(Number of contaminating bacteria) 9 (Bacterial viru-
lence)/(Host’s infection defense activity) [2].
The risk of SSI is regulated by the number of bacteria,
virulence (the development of infection), and defensive
activity against this virulence, because contaminating bac-
teria are resident ﬂora of the operative ﬁeld. The principle of
selection of the indications for prophylactic use of anti-
bacterial drugs is to select the bacteria showing large
numbers and high pathogenicity, among the indigenous
bacterial ﬂora at the operative site. According to this prin-
ciple, Table 1 shows these bacteria as indications for pro-
phylactic use of antibacterial agents according to typical
operative sites and the attitudes toward the antibacterial
agents corresponding to these bacteria as indications for the
agents. Resident ﬂora of the skin become problematic in
hernia, mammary gland, thyroid gland, and cardiovascular
operations. The main bacteria are coagulase-negative
Staphylococcus (CNS) and Staphylococcus aureus (because
of high pathogenicity).
Propionibacterium species, i.e., anaerobic bacteria
existing in the excretory duct of the sebaceous gland, is
excluded from the indications for prophylactic use of anti-
bacterial agents based on the amount of bacteria and viru-
lence. On the other hand, the frequency of anaerobes
existing as resident ﬂora in the upper gastrointestinal oper-
ative ﬁeld is essentially low except as compared to that in the
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oral cavity. However, anaerobic cocci become an issue as
contaminating bacteria in esophago-gastroduodenal opera-
tions because the amount of bacteria in the oral cavity is
extremely large. These bacteria, as well as Staphylococcus
species and Escherichia coli, are included among the indi-
cations for prophylactic use of antibacterial agents. The
appendix contains the large amounts of Escherichia coli,
i.e., gram-negative bacilli, as resident ﬂora, and the Bacte-
roides fragilis group as anaerobic gram-negative bacilli.
Therefore, these two species are indications for the pro-
phylactic use of antibacterial agents. The pathogenicity of
Bacteroides species involves the ability to form abscesses;
as to the pattern (1st phase), oxidation–reduction potential in
the infectious tissue is reduced with multiplication of aerobe
(to be precise, Escherichia coli, i.e., a facultative anaerobe,
is frequently involved in this action). In response to the
decrease in potential, the situation of anaerobic multiplica-
tion is established, and the abscess-forming activity is
exerted via bacterial multiplication. Such a pattern of
infection is called ‘‘biphasic infection’’, and shows the
pathogenicity of anaerobic bacteria [3]. Many strains of the
B. fragilis group produce b-lactamase rendering b-lactams,
which were originally efﬁcacious, ineffective. For this rea-
son, prophylactic antibacterial agents, indications for which
include mainly these two bacterial species, are selected for
surgery on the appendix.
With regard to the bacteria included among the indica-
tions for prophylactic antibacterial agents in biliary tract
system operations, the assessment of causative bacteria of
biliary infection as primary infections [4] revealed
Enterococcus species to most frequently be detected as
single bacterial species. These bacteria show low patho-
genicity. A report has shown that there are no difference in
therapeutic outcomes among polymicrobial infections
involving enterococci, even though Enterococcus species
are excluded from the indications for treatment of these
infections [5]. Therefore, the bacteria may be excluded
from the prophylaxis treatment effect. The next most fre-
quently detected bacteria after Enterococcus species are
gram-negative bacilli including Escherichia coli, Klebsi-
ella pneumoniae, and Enterobacter species. These bacteria
are also included among the indications for prophylactic
antibacterial agents from the viewpoint of pathogenicity.
The point is whether or not anaerobes are included as
indications. They may be excluded from the indications, as
a rule, because the rate of detection of anaerobic gram-
negative bacilli such as the B. fragilis group, in the pres-
ence of biliary infections, is lower than 10%.
Table 1 The bacteria included in the indications for prophylactic antibacterial agents, and those which should be selected according to types of
the operation
Types of surgery Bacterial species that should be
included in the indications
Antibacterial agents
Hygienic surgery
Mammary gland, thyroid gland,
cardiovascular surgery
Staphylococcus aureus
Coagulase-negative Staphylococcus
First-generation cephalosporins (cefazolin, etc.)
Penicillins (ampicillin/cloxacillin combination,
penicillins with b-lactamase inhibitors)
Upper gastrointestinal surgery
Esophagus
Gastrectomy
Aerobic gram-negative bacilli (mainly,
Escherichia coli, and occasionally, Klebsiella
pneumoniae)
Staphylococcus species, Anaerobic gram-
positive cocci in the oral cavity
(Peptostreptococcus species, etc.)
Anaerobic gram-positive cocci in the oral cavity
are included in the indications as anaerobes
First-generation cephalosporins (cefazolin, etc.)
Second-generation cephalosporins (cefotiam,
etc.)
Penicillins can also be used for treatment of
some cases of gastrectomya.
Appendectomy (non-perforating) Aerobic gram-negative bacilli (mainly, E. coli)
Bacteroides fragilis group
Staphylococcus species
B. fragilis group in the intestinal tract are
included in the indications as anaerobes
Cephamycins (cefmetazole, etc.)
Oxacephems (ﬂomoxef, etc.)
Penicillins (sulbactam/ampicillin, tazobactam/
piperacillin, etc.)
Hepatobiliary surgery Aerobic gram-negative bacilli (E. coli,
K. pneumoniae, Enterobacter species)
Staphylococcus species
First- and second-generation cephalosporins
(cefazolin, cefotiam, etc.)
Penicillins (piperacillin, etc.)
Colorectal surgery Aerobic gram-negative bacilli
(E. coli, K. pneumoniae, etc.)
B. fragilis group
Staphylococcus species
Intestinal B. fragilis is included
in the indications as anaerobes
Cephamycins (cefmetazole, etc.)
Oxacephems (ﬂomoxef, etc.)
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In operations on the colon and rectum, the bacteria,
which are included among the indications for prophylactic
antibacterial agents because of the number of bacteria and
their pathogenicity, among the resident ﬂora of these sites
(colon and rectum) are mainly gram-negative bacilli
including Escherichia coli and K. pneumoniae and anaer-
obic gram-negative bacilli including the B. fragilis group.
There are two methods of administering prophylactic
antibacterial agents in colorectal operations; control of
intestinal bacterial ﬂora by preoperative oral administration
of antibacterial agents and intravenous administration of
the drugs during the operation.
Even though mechanical treatment of the intestinal tract
with cathartics is actually conducted before the operation, the
operative ﬁeld is contaminated with intra-intestinal bacteria
including anaerobes at a high frequency [6]. To reduce these
contaminating bacteria, a non-absorbable oral antibacterial
agents [kanamycin (KM) or neomycin is frequently selected
for gram-negative bacilli, and metronidazole or erythromy-
cin (EM) is frequently selected for anaerobe] is administered
in 3 divisions the day before the operation. The CDC in the
US also recommends this method in their guidelines [2]. In
Japan, however, antibacterial agents are not administered due
to the prevalence of methicillin-resistant Staphylococcus
aureus (MRSA) in many institutions, because the adminis-
tration period for oral antibacterial agents was as long as
3 days or more, leading to microbial substitution and the
current high rate of detection of MRSA. In actuality, the
usefulness of preoperative administration of oral antibacte-
rial agents for colectomy is not clear, whereas the incidence
of postoperative infections is high with rectal operations.
Further studies are needed to address these issues.
The indications for systemic administration include
anaerobe such as the B. fragilis group and gram-negative
bacilli such as Escherichia coli and K. pneumoniae, as
described earlier. Staphylococcus species that constitutes
resident ﬂora of the skin is also included in the indications
for selecting prophylactic antibacterial drugs.
The timing of the start of administration, the dose, and
the administration period are the same among prophylactic
antibacterial agents, regardless of the presence or absence
of the involvement of anaerobe with infections.
Postoperative infections with anaerobic bacteria
Characteristics of postoperative infections
with anaerobic bacteria
Figure 1 shows changes in the isolates in postoperative
infections. Anaerobic gram-positive and -negative bacteria
tend to increase, while aerobic bacteria tend to decrease.
The isolates in primary infections in gastroenterological
surgery (so-called community acquired infections such as
peritonitis and gallbladder tract inﬂammation) were
compared with the isolates from postoperative infections in
gastroenterological surgery. As shown in Fig. 2, anaerobic
gram-positive cocci including Peptostreptococcus species
and other anaerobic gram-negative bacilli including
Prevotella species are reduced, whereas the rate of detection
of the B. fragilis group is unchanged. These bacteria are
considered to be the most problematic from the aspect of
drug sensitivity as well.
The rate of detection of anaerobic bacteria was assessed
according to postoperative infections. As shown in Fig. 3,
the rate of detection is highest in wound infections; the
wound is contaminated with resident bacterial ﬂora of the
gastrointestinal tract during the gastrointestinal operation,
leading to wound infections. The next highest rate of
detection is obtained in postoperative peritonitis after
wound infection. In many cases, resident ﬂora of the
intestinal tract leak out because of suture insufﬁciency,
leading to the bacteria becoming infectious agents. The
frequency at which anaerobe contribute to postoperative
hepatobiliary infections, is lowest. Aerobic gram-negative
bacilli are frequently involved in these infections. Most
infection cases involving anaerobic bacteria are caused by
the B. fragilis group. Attention should be paid to these
matters when selecting antibacterial drugs.
Characteristics of the anaerobic infectious lesions are: (1)
malodorous secretions and pus, (2) gas in the infectious
lesions, (3) the presence of bacteria on microscopic exami-
nation, negative ﬁndings on aerobic culture, and so on [7].
Measures to counter postoperative anaerobic infections
Postoperative anaerobic infections are treated surgically
and by antibacterial chemotherapy, as a rule. Surgical
Fig. 1 Changes in the isolated in postoperative infections. The study
group on bacteria isolated from surgical patients with infections
(1983–2004)
64 J Infect Chemother (2011) 17 (Suppl 1):62–66
123
treatment means drainage, i.e., adequate opening of
infected lesions. There are also many cases of superﬁcial
incisional SSI as wound infections, which do not require
antibacterial chemotherapy. They are managed with ade-
quate drainage alone, i.e., opening of the wound by
extraction of the stitches. Even the lesions which cannot be
opened because of intraperitoneal abscess and so on, need
to be drained under ultrasonographic or computed tomog-
raphy (CT) guidance.
Much attention should be paid to the following aspects
of antibacterial chemotherapy: Fundamentally, aminogly-
cosides have no antibacterial activity against anaerobic
bacteria, many anaerobic gram-negative bacilli including
the B. fragilis group produce b-lactamase, and many of
them are resistant to penicillins and cephalosporins; in
mixed infections some antibacterial agents may also lose
their antibacterial action even against sensitive bacteria as
a result of resolution in these mixed infections. Thus, it is
necessary to treat these infections by recognizing these
features of antibacterial chemotherapy.
With regard to the drugs selected, anaerobic gram-
positive cocci are not a particularly major issue, because
many drugs such as b-lactams generally have excellent
antibacterial action against cocci. The bacteria that become
an issue are anaerobic gram-negative bacilli, particularly
the B. fragilis group. In recent years, 30% on average of
strains have shown resistance to clindamycin (CLDM), and
the numbers of bacteria resistant to cephamycins and ox-
acephems are gradually increasing.
The drugs, which show antibacterial action against the
B. fragilis group at an MIC90 of 4 lg/ml or less, are car-
bapenems, tazobactam/piperacillin (TAZ/PIPC), and sul-
bactam/cefoperazone (SBT/CPZ) (to which the rate of
bacterial resistance is low), and 20–40% of the bacteria are
resistant to cefmetazole (CMZ), ﬂomoxef (FMOX) and
CLDM [8]. In postoperative infections like these, in which
anaerobic bacteria are involved, cephamycins, such as
CMZ, and oxacephems are prophylactically administered
for the purpose of preventing infections in many cases.
Therefore, carbapenems or combinations, such as TAZ/
PIPC and SBT/CPZ, are likely to be selected for empiric
treatment of postoperative infections with a single drug,
when anaerobic bacterial involvement appears to be pres-
ent. After the causative bacteria have been clariﬁed on
sensitivity tests, antibacterial agents should be selected by
referring to these test results.
Conclusion
The ratio of anaerobic bacteria involving postoperative
infections tends to gradually increase because of the reg-
ulations applied to prophylactic antibacterial agents, which
have been established in recent years. It would appear to be
important for managing postoperative infections to treat on
the basis of recognition of these changes.
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